Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors

Summary

Phase I trial to study the effectiveness of combining bortezomib with docetaxel in treating patients who have advanced solid tumors. Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining bortezomib with docetaxel may kill more tumor cells

Timeline

Start

2002-08

Primary completion

2009-02

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications